In conclusion, our results support that HLA-G could be involved in glioblastoma evasion to antiangiogenic therapy [100, 101], since de novo acute hypoxic stress will lead to HIF-1 stabilization and then binding to the exon 2 HRE. Here, HIF1A is linked to glioblastoma.